Atropine Sulfate Solution
NDC Package 0065-0817-01
Package Information
Atropine Sulfate solution is a medication used before eye examinations (e.g., refraction) and to treat certain eye conditions (e.g., uveitis). This formulation utilizes a solution delivery system. Marketed by Alcon Laboratories, Inc., this product is identified by NDC 0065-0817 and is authorized under FDA application NDA208151.
Identification & Billing
- RxCUI: 1190655 - atropine sulfate 1 % Ophthalmic Solution
- RxCUI: 1190655 - atropine sulfate 10 MG/ML Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0065 - Alcon Laboratories, Inc.
- 0065-0817 - Atropine Sulfate
- 0065-0817-01 - 1 BOTTLE, DROPPER in 1 CARTON / 5 mL in 1 BOTTLE, DROPPER
- 0065-0817 - Atropine Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0065-0817). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0065-0817-01 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 5 ml in 1 bottle, dropper of Atropine Sulfate, a human prescription drug labeled by Alcon Laboratories, Inc.. This solution is formulated for ophthalmic use and contains atropine sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alcon Laboratories, Inc. on November 01, 2022. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used before eye examinations (e.g., refraction) and to treat certain eye conditions (e.g., uveitis). It belongs to a class of drugs known as anticholinergics. Atropine works by widening (dilating) the pupil of the eye.
How is this Alcon Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00065081701. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.